CASE STUDY
Validate product fit market assumptions to determine your price point and launch strategy.
Set realistic expectations around how and when coverage will occur, and what restrictions are likely.
Track policy updates and monitor key accounts in the hectic post-launch timeframe.
As one small biopharma company awaited FDA approval, it partnered with MMIT to do its homework on market dynamics to ensure immediate patient access to its oncology therapies.
In this case study, learn how MMIT’s claims, coverage and restriction data helped the company better understand payer mix and utilization analytics so they could prepare to take on their competitors.